Filing Details
- Accession Number:
- 0001127602-24-014811
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-09 17:15:23
- Reporting Period:
- 2024-05-08
- Accepted Time:
- 2024-05-09 17:15:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657720 | Pascal Deschatelets | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-08 | 78,907 | $4.31 | 1,194,890 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-08 | 56,335 | $42.15 | 1,138,555 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 22,472 | $42.85 | 1,116,083 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-08 | 100 | $44.03 | 1,115,983 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-05-08 | 78,907 | $0.00 | 78,907 | $4.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 108,622 | 2027-08-22 | No | 4 | M | Direct |
Footnotes
- This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/8/2023.
- This transaction was executed in multiple trades at prices ranging from $41.575 - $42.570. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $42.575 - $43.545. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This stock option was granted on 08/21/2017 and is fully vested.
Billionaire Hedge Funds
